Keyphrases
Magnetic Resonance Imaging
100%
Controlled Release
100%
Pancreatic Cancer
100%
Targeted Therapy
100%
Theranostic Nanoparticles
100%
Gemcitabine
100%
Iron Oxide Nanoparticles
77%
Amino-terminal Fragment
55%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
44%
Tumor Cells
22%
Therapeutic Approaches
22%
Contrast Enhancement
22%
Receptor Targets
22%
Nanoparticles
11%
Tumor
11%
Targeted Nanoparticles
11%
Linker
11%
Drug Delivery
11%
Cancer Cells
11%
Human Cancer
11%
Magnetic Resonance Imaging Contrast Agents
11%
Targeted Delivery
11%
Nanoparticles Effect
11%
Receptor-mediated Endocytosis
11%
Targeted Imaging
11%
Therapeutic Agents
11%
Magnetic Iron Oxide Nanoparticles
11%
Imaging Approach
11%
Stromal Cells
11%
Receptor-binding Domain
11%
Systemic Administration
11%
Theranostics
11%
Physical Barrier
11%
Cleavable
11%
Xenograft Mice
11%
Therapeutic Effect
11%
Natural Ligands
11%
Tetrapeptide
11%
Tumor Stroma
11%
Enzymatic Degradation
11%
Targeted Therapeutics
11%
Lysosomal Enzymes
11%
Drug-resistant Tumor
11%
Cancer Xenograft
11%
Fragment Peptide
11%
Residual Tumor
11%
Human Pancreatic Cancer
11%
Chemotherapy Drugs
11%
Tumor Stromal Barrier
11%
Intracellular Release
11%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Nanoparticle
100%
Pancreas Cancer
100%
Targeted Therapy
100%
Gemcitabine
100%
Controlled Release
100%
Ultrasmall Superparamagnetic Iron Oxide
88%
Neoplasm
55%
Amino Terminal Sequence
55%
Urokinase Receptor
44%
Stroma
22%
Receptor
11%
Malignant Neoplasm
11%
Tumor Cell
11%
Endocytosis
11%
Cancer Cell
11%
Stromal Cell
11%
Systemic Administration
11%
Stromal Tumor
11%
Therapeutic Agent
11%
Tumor Xenograft
11%
Receptor Binding
11%
Tetrapeptide
11%
Therapy Effect
11%
Peptide Fragment
11%
Lysosome Enzyme
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Pancreas Cancer
100%
Controlled Release
100%
Gemcitabine
100%
Iron Oxide Nanoparticle
88%
Neoplasm
77%
Urokinase Receptor
44%
Malignant Neoplasm
22%
Receptor-Mediated Endocytosis
11%
Chemotherapy
11%
Nude Mouse
11%
Receptor
11%
Systemic Administration
11%
Therapeutic Effect
11%
Peptide Fragment
11%
Tetrapeptide
11%
Lysosome Enzyme
11%